A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006857:Hydroflumethiazide / Q000008:administration & dosage / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D013148:Spironolactone; D006857:Hydroflumethiazide; D008750:Methyldopa